Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07469189) titled 'A Study on Hydroxocobalamin Given to Healthy Individual to Monitor Symptoms' ... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07469345) titled 'Bruxism, Pelvic Pain, Erectile Dysfunction, and Anxiety in Young Adult Men' o... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470437) titled 'The Mouth Matters in Mental Health Trial -2' on March 10. Study Type: Interv... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470541) titled 'Viromes in Infants Presenting With a Septic Syndrome' on March 10. Study Typ... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470905) titled 'Development and Preclinical Validation of DiaBuddy, a Point-of-Care Decision ... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470957) titled 'A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus W... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471009) titled 'Development of Patient Derived Xenografts (PDXs) and Analysis of Tyrosine Kin... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471061) titled 'Acute Ischemic Stroke Involves Significant Inflammatory Response. This Prospe... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471269) titled 'Online Pain Neuroscience Education For Fear Of Childbirth' on March 10. Stud... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471841) titled 'Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Receiv... Read More